SEC Form S-3 filed by Lyell Immunopharma Inc. - Quantisnow

Retrieved on: 2024-11-29 21:33:18

Tags for this article:

U.S. Securities and Exchange Commission

SEC filings

73rd United States Congress

Stock market

Securities Act

Registration statement

Securities Exchange Act

Security

Form S-3

Regulation S-K

Lyell Immunopharma Inc.

Skadden Arps Slate Meagher & Flom LLP

Click the tags to see associated articles and topics

SEC Form S-3 filed by Lyell Immunopharma Inc. - Quantisnow. View article details on hiswai:

Excerpt

Preliminary Prospectus · 37,499,981 · Shares of Common Stock · Neither the Securities and Exchange Commission nor any state securities commission has ...

Article found on: quantisnow.com

View Original Article